2026 Lotte Executive Appointments
Joint Management Responsibility with Current CEO Park James

Shin Youl, the eldest son of Lotte Group Chairman Shin Dongbin and a third-generation member of the owner family, will take on the role of Co-CEO of Lotte Biologics, becoming responsible for the group’s new business ventures.


Shin You-yeol, Co-CEO of Lotte Biologics. Provided by Lotte

Shin You-yeol, Co-CEO of Lotte Biologics. Provided by Lotte

View original image

On November 26, Lotte announced through its regular executive appointments that Vice President Shin will serve as Co-CEO of Lotte Biologics alongside the current CEO, Park James.


Born in 1986, Vice President Shin joined Lotte Japan in 2020, was promoted to Executive Director of Lotte Chemical’s Japan branch in 2022, became CEO of Lotte Financial in 2023, and last year was promoted to Vice President of Lotte Holdings, advancing rapidly through the ranks.



Previously, as Head of the Future Growth Division at Lotte Holdings, Vice President Shin led the group’s global business and new business strategies. With this appointment, he will now jointly oversee the group’s major new business, the bio sector. In addition, he will take on a key role in the newly established Strategy Control organization at Lotte Holdings, spearheading business innovation and the transformation of the group’s business portfolio.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.

Today’s Briefing